Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-10-30

Clinical Trial Update: P2Y12 Inhibitors Utilization in Bifurcation and Chronic Total Occlusion PCI

View source ↗

Summary

A completed clinical trial update examining the use of P2Y12 inhibitors in complex percutaneous coronary intervention, including bifurcation and chronic total o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • P2Y12 inhibitors (class) (P2Y12 receptor inhibitors)

Snippet

Sponsor: G. d'Annunzio University | Conditions: Coronary Arteriosclerosis | Status: COMPLETED